EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages

Michiko Shimoda iD, Tomoki Inagaki iD, Ryan R Davis, Alexander Merleev, Clifford G Tepper, Emanual Maverakis, Yoshihiro Izumiya iD

PLOS Pathogens · 26.10.2023 · 19 (10) · e1011703

DOI: 10.1371/journal.ppat.1011703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 26.10.2023. Verfasst von Michiko Shimoda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, California, United States of America. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Sarcoma, Kaposi, Herpesviridae Infections. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic double-stranded DNA virus and the etiologic agent of Kaposi’s sarcoma and hyperinflammatory lymphoproliferative disorders. Understanding the mechanism by which KSHV increases the infected cell population is crucial for curing KSHV-associated diseases. Using scRNA-seq, we demonstrate that KSHV preferentially infects CD14 + monocytes, sustains viral lytic replication through the viral interleukin-6 (vIL-6), which activates STAT1 and 3, and induces an inflammatory gene expression program. To study the role of vIL-6 in monocytes upon KSHV infection, we generated recombinant KSHV with premature stop codon (vIL-6(-)) and its revertant viruses (vIL-6(+)). Infection of the recombinant viruses shows that both vIL-6(+) and vIL-6(-) KSHV infection induced indistinguishable host anti-viral response with STAT1 and 3 activations in monocytes; however, vIL-6(+), but not vIL-6(-), KSHV infection promoted the proliferation and differentiation of KSHV-infected monocytes into macrophages. The macrophages derived from vIL-6(+) KSHV infection showed a distinct transcriptional profile of elevated IFN-pathway activation with immune suppression and were compromised in T-cell stimulation function compared to those from vIL-6(-) KSHV infection or uninfected control. Notably, a viral nuclear long noncoding RNA (PAN RNA), which is required for sustaining KSHV gene expression, was substantially reduced in infected primary monocytes upon vIL-6(-) KSHV infection. These results highlight the critical role of vIL-6 in sustaining KSHV transcription in primary monocytes. Our findings also imply a clever strategy in which KSHV utilizes vIL-6 to secure its viral pool by expanding infected monocytes via differentiating into longer-lived dysfunctional macrophages. This mechanism may facilitate KSHV to escape from host immune surveillance and to support a lifelong infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanSarcoma, KaposiHerpesviridae InfectionsHumansInterleukin-6MonocytesMacrophagesImmunologic FactorsVirus Replication

Substanzen

Interleukin-6Immunologic Factors

Autor:innen und Institutionen

  • Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, California, United States of America.
  • UC Davis Comprehensive Cancer Center, Sacramento, California, United States of America.
  • Department of Pathology and Laboratory Medicine, School of Medicine, University of California, Davis, Sacramento, California, United States of America.
  • Department of Biochemistry and Molecular Medicine, School of Medicine, UC Davis, Sacramento, California, United States of America.
  • Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California, United States of America.

ORCID-Profile: Michiko Shimoda, Tomoki Inagaki, Yoshihiro Izumiya

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • National Cancer Institute
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • UC Davis Dermatology

Zitieren

APA

Shimoda, M., Inagaki, T., Davis, R. R., Merleev, A., Tepper, C. G., Maverakis, E., & Izumiya, Y. (2023). Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages. PLOS Pathogens, 19(10), e1011703. https://doi.org/10.1371/journal.ppat.1011703

Vancouver

Shimoda M, Inagaki T, Davis RR, Merleev A, Tepper CG, Maverakis E, et al. Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages. PLOS Pathogens. 2023;19(10):e1011703. doi:10.1371/journal.ppat.1011703

BibTeX
@article{Shimoda2023,
  author = {Shimoda, Michiko and Inagaki, Tomoki and Davis, Ryan R and Merleev, Alexander and Tepper, Clifford G and Maverakis, Emanual and Izumiya, Yoshihiro},
  title = {Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages},
  journal = {PLOS Pathogens},
  year = {2023},
  volume = {19},
  number = {10},
  pages = {e1011703},
  doi = {10.1371/journal.ppat.1011703}
}
Kostenlos starten →